Dose Enters Cardiovascular Market With Clinical Liquid Supplement
Dose has launched a doctor-formulated liquid supplement designed to support healthy blood pressure, marking the company's first expansion beyond liver and cholesterol health. The product distinguishes itself through a randomized, double-blind, placebo-controlled study that verified the efficacy of the finished formula rather than relying on individual ingredient research.
The new supplement, Dose for Blood Pressure, arrives after 18 months of development and over 100 iterations. Unlike typical market offerings, the formula utilizes a proprietary blend of Veldt Grape, turmeric, CoQ10, grapeseed, and folate. According to clinical data, 91% of participants showed a positive impact on systolic blood pressure, while 74% saw improvements in diastolic readings after four weeks of twice-daily use.
Founder Vasu Goyal noted that the company aims to address 'silent' health markers that often go unnoticed until clinical lab work reveals a change. By maintaining a liquid format, Dose seeks to improve absorption while providing a measurable, proactive alternative to traditional pill-based supplements. Dr. Jiah Pearson-Leary, Director of Science at Dose, emphasized that the multi-mechanism approach is intended to support the body’s interconnected vascular systems rather than targeting a single biological pathway.
The product is available on the company’s website starting August 31, with pricing set at $90 for a three-pack of 16 fl oz bottles or $160 for a six-pack. The supplement is vegan, kosher, and non-GMO, positioning it as a cohesive addition to the brand’s existing portfolio of health-support products.
Comments (0)
No comments yet. Be the first!